CDs

Question 1

Pre-cursor B-cells

Answer 1

CD10
CD19
CD20

Question 2

hematopoietic stem cell CD

Answer 2

CD34

Question 3

Hodgkin’s lymphpma CD

Answer 3

CD15
CD30
PAX 5

Question 4

T-cell markers

Answer 4

CD2-CD8

Question 5

Hairy Cell Leukemia CD markers

Answer 5

CD45
CD103
CD11c

Question 6

what CD not found in Hairy cell?

Answer 6

NOT CD21

Question 7

B-cell marker in CLL/SLL

Answer 7

CD23

Question 8

IL-2 receptor

Answer 8

CD25

Question 9

Decay Accelerating Factor

Answer 9

CD55

Question 10

CD59

Answer 10

membrane inhibitor of lysis

Question 11

which B-cell lymphomas have T-cell marker? which T-cell marker

Answer 11

CLL/SLL
Mantle Cell
coexpress CD5

Question 12

lymphocyte predominant CD

Answer 12

CD20+

CD15- and CD30-

Question 13

Adult T-cell lymphoma CD marker

Answer 13

CD25 (IL-2 receptor)

Question 14

Mycosis fungoides CD marker

Answer 14

CD4+ T-cell;

Question 15

CD19, 20, 23 and 5

Answer 15

CLL/SLL

Question 16

Ig light chain and CD19, 20, 22, 45, 103 and annexin but NOT CD21

Answer 16

Hairy Cell Leukemia

Question 17

CD10, CD19, CD34;

terminal deoxynucleotidyl transferase [TdT]).

Answer 17

Blast Phase (CML)

Question 18

Anti-CD3 monoclonal Ab

Answer 18

Depletes T-cells

Question 19

Anti-IL-2 receptor Ab (CD25)

Answer 19

blocks T-cell proliferation

Question 20

CTLA4-Ig

Answer 20

inhibits T-cell activation

Question 21

Binds to the CD20 antigen on the surface of pre-B cells and mature B cells

Answer 21

Rituximab

Question 22

beta2-integrin CD

Answer 22

CD18

LADI

Question 23

Reduced numbers of CD3+ T-cells

Answer 23

Diagnosis–>DiGeorge Syndrome

Question 24

Drug that is anti-CD3

Answer 24

Muromonab

Question 25

Mouse monoclonal Ab against human CD3 (cell surface molecule for T-cell receptor activation)

Answer 25

Muromonab

Question 26

Abs against CD25—the high affinity IL-2 receptor

Answer 26

Daclizumab and Basiliximab: